• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Surges Over 200 Points; Crude Oil Rises 2%

    1/9/23 12:07:11 PM ET
    $ALBO
    $AMYT
    $AYI
    $BITF
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALBO alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.

    The Dow traded up 0.70% to 33,865.87 while the NASDAQ rose 2.09% to 10,790.16. The S&P 500 also rose, gaining, 1.25% to 3,943.66.

    Check This Out: Bitcoin Tops This Key Level; Gala, Solana Among Top Gainers


    Leading and Lagging Sectors


    Information technology shares gained by 2.8% on Monday. Meanwhile, top gainers in the sector included Duck Creek Technologies, Inc. (NASDAQ:DCT), up 47%, and Bitfarms Ltd. (NASDAQ:BITF), up 34%.


    In trading on Monday, health care shares fell by 0.4%.


    Top Headline


    Acuity Brands, Inc (NYSE:AYI) reported better-than-expected earnings and sales results for its first quarter.


    Acuity Brands reported first-quarter FY23 net sales growth of 7.8% year-over-year to $997.9 million, beating the consensus of $984.5 million. Adjusted EPS of $3.29 beat the consensus of $3.00.

     


    Equities Trading UP

     

    • CinCor Pharma, Inc. (NASDAQ:CINC) shares shot up 143% to $28.68 after AstraZeneca announced it will acquire the company for $26 per share in cash.
    • Shares of Amryt Pharma plc (NASDAQ:AMYT) got a boost, shooting 108% to $14.60 after Chiesi Farmaceutici announced it will acquire the company for $14.50 per ADS plus contingent value rights of up to an additional $2.50 per ADS.
    • Albireo Pharma, Inc. (NASDAQ:ALBO) shares were also up, gaining 93% to $44.00 after Ipsen announced it will acquire the company for $42 per share plus a contingent value right of $10 per share.

     

    Equities Trading DOWN

    • Calithera Biosciences, Inc. (NASDAQ:CALA) shares tumbled 81% to $0.6801. Calithera Biosciences announced board approval of complete liquidation and dissolution.
    • Shares of Cutera, Inc. (NASDAQ:CUTR) were down 20% to $32.31 after the company reported preliminary unaudited financial results for FY22. The company expects to report revenue in the range of $252 million to $253 million for FY22.
    • Cerus Corporation (NASDAQ:CERS) was down, falling 23% to $2.9085. Cerus sees preliminary Q4 product revenues of $44 million, up 10% year over year.


    Also Check This Out: Why Market Expert Says It's Time To Buy North Asian Stock Sectors


    Commodities

    In commodity news, oil traded up 2% to $75.24 while gold traded up 0.7% at $1,882.50.


    Silver traded up 0.1% to $23.995 on Monday while copper rose 3.3% to $4.0390.

     


    Euro zone


    European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.88%, London’s FTSE 100 gained 0.33% while Spain’s IBEX 35 Index slipped 0.07%. The German DAX gained 1.25%, French CAC 40 climbed 0.68% and Italy’s FTSE MIB Index gained 0.81%.


    The Eurozone’s unemployment rate came in unchanged at 6.5% for November from the prior month's all-time low level, while unemployment rate in Italy declined to 7.8% in November.


    France’s current account deficit increased to EUR 6.8 billion in November versus a revised EUR 3.4 billion in the prior month, while trade deficit increased to EUR 13.8 billion in November. Industrial production in Germany rose 0.2% month-over-month in November.

     


    Asia Pacific Markets


    Asian markets closed higher on Monday, with the Hong Kong’s Hang Seng Index climbing 1.89%, and China’s Shanghai Composite Index adding 0.58%.


    Private house approvals in Australia declined 2.2% month-over-month to 9,142 units in November, while building permits declined by 9% month-over-month to 13,898 units in November.

     

    Economics


    Data on consumer credit for November will be released at 3:00 p.m. ET.

     

    Now Read This: Fear & Greed Index Moves To 'Neutral' Zone Following Jobs Data


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 103,086,920 cases with around 1,121,090 deaths. India confirmed a total of at least 44,681,170 cases and 530,720 deaths, while France reported over 39,407,720 COVID-19 cases with 162,640 deaths. In total, there were at least 668,796,070 cases of COVID-19 worldwide with more than 6,714,170 deaths.

    Get the next $ALBO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALBO
    $AMYT
    $AYI
    $BITF

    CompanyDatePrice TargetRatingAnalyst
    Bitfarms Ltd.
    $BITF
    1/27/2026$3.00Outperform → Mkt Perform
    Keefe Bruyette
    Acuity Inc.
    $AYI
    10/2/2025$330.00 → $390.00Buy
    TD Cowen
    Bitfarms Ltd.
    $BITF
    9/15/2025Buy
    Compass Point
    Acuity Inc.
    $AYI
    9/2/2025$380.00Equal Weight → Overweight
    Wells Fargo
    Acuity Inc.
    $AYI
    1/14/2025$304.00 → $370.00Equal-Weight → Overweight
    Morgan Stanley
    Bitfarms Ltd.
    $BITF
    1/8/2025Outperform
    Keefe Bruyette
    Acuity Inc.
    $AYI
    1/6/2025$304.00Equal-Weight
    Morgan Stanley
    Acuity Inc.
    $AYI
    1/2/2025Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $ALBO
    $AMYT
    $AYI
    $BITF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief Financial Officer Holcom Karen J exercised 897 shares at a strike of $239.76 and sold $1,538,110 worth of shares (4,974 units at $309.23), decreasing direct ownership by 16% to 21,523 units (SEC Form 4)

    4 - ACUITY INC. (DE) (0001144215) (Issuer)

    1/30/26 4:02:35 PM ET
    $AYI
    Building Products
    Consumer Discretionary

    SEC Form 4 filed by Director Sachleben Mark

    4 - ACUITY INC. (DE) (0001144215) (Issuer)

    1/23/26 4:14:28 PM ET
    $AYI
    Building Products
    Consumer Discretionary

    SEC Form 4 filed by Director O'Shaughnessy Laura

    4 - ACUITY INC. (DE) (0001144215) (Issuer)

    1/23/26 4:13:56 PM ET
    $AYI
    Building Products
    Consumer Discretionary

    $ALBO
    $AMYT
    $AYI
    $BITF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bitfarms Announces U.S. Redomiciliation Plan and Intent to Rebrand as Keel Infrastructure

    TORONTO, Ontario and NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American digital infrastructure and energy company, today announced that its Board of Directors has approved a plan of arrangement (the "Arrangement") under which the Company will redomicile from Canada to the United States (the "US Redomiciliation"), subject to receipt of shareholder, stock exchange and court approvals. The Arrangement is the culmination of a comprehensive strategic review process undertaken by the Board over the past 12 months, including ongoing analysis of investor sentiment and capital markets trends to identify opportunities to enhan

    2/6/26 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Acuity Announces Increase in Quarterly Dividend

    Atlanta, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE:AYI) Board of Directors (the "Board") increases the quarterly dividend by 17% percent to 20 cents per share from 17 cents per share. The dividend is payable on February 13, 2026, to shareholders of record on February 2, 2026. About Acuity  Acuity Inc. (NYSE:AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people's lives. We achieve growth throug

    1/22/26 4:15:00 PM ET
    $AYI
    Building Products
    Consumer Discretionary

    DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice

    Cerus Corporation (NASDAQ:CERS) today announced the start of the INITIATE study by the German Red Cross Blood Donation Service Baden-Württemberg – Hessen and its subsidiary organization, the German Red Cross Blood Donation Service North-East. The prospective, multicenter, non-interventional safety study, sponsored by DRK Blood Donation Service Baden-Württemberg-Hessen, is the first of its kind in Germany to evaluate the routine use of pathogen-inactivated platelet concentrates utilizing the INTERCEPT Blood System in a clinical setting. Platelet concentrates (PC) are an important part of the blood supply in Germany. They are needed for patients with low platelet count or impaired platelet

    1/22/26 7:30:00 AM ET
    $CERS
    EDP Services
    Technology

    $ALBO
    $AMYT
    $AYI
    $BITF
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BYLVAY issued to ALBIREO PHARMA INC

    Submission status for ALBIREO PHARMA INC's drug BYLVAY (ORIG-1) with active ingredient ODEVIXIBAT has changed to 'Approval' on 07/20/2021. Application Category: NDA, Application Number: 215498, Application Classification: Type 1 - New Molecular Entity

    7/21/21 11:28:05 AM ET
    $ALBO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALBO
    $AMYT
    $AYI
    $BITF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bitfarms downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Bitfarms from Outperform to Mkt Perform and set a new price target of $3.00

    1/27/26 8:40:33 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    TD Cowen reiterated coverage on Acuity with a new price target

    TD Cowen reiterated coverage of Acuity with a rating of Buy and set a new price target of $390.00 from $330.00 previously

    10/2/25 7:48:53 AM ET
    $AYI
    Building Products
    Consumer Discretionary

    Compass Point resumed coverage on Bitfarms

    Compass Point resumed coverage of Bitfarms with a rating of Buy

    9/15/25 7:53:17 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    $ALBO
    $AMYT
    $AYI
    $BITF
    SEC Filings

    View All

    $ALBO
    $AMYT
    $AYI
    $BITF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 6-K filed by Bitfarms Ltd.

    6-K - Bitfarms Ltd (0001812477) (Filer)

    2/6/26 5:08:22 PM ET
    $BITF
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Bitfarms Ltd.

    6-K - Bitfarms Ltd (0001812477) (Filer)

    2/6/26 7:15:27 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Cerus Corporation filed SEC Form 8-K: Leadership Update

    8-K - CERUS CORP (0001020214) (Filer)

    1/23/26 4:24:31 PM ET
    $CERS
    EDP Services
    Technology

    Director Gregory Dean A. bought $31,250 worth of shares (25,000 units at $1.25), increasing direct ownership by 41% to 86,725 units (SEC Form 4)

    4 - CERUS CORP (0001020214) (Issuer)

    8/25/25 3:25:00 PM ET
    $CERS
    EDP Services
    Technology

    Director Gregory Dean A. bought $2,932 worth of shares (1,725 units at $1.70), increasing direct ownership by 3% to 61,725 units (SEC Form 4)

    4 - CERUS CORP (0001020214) (Issuer)

    1/2/25 5:46:11 PM ET
    $CERS
    EDP Services
    Technology

    Shan Hua bought $4,975 worth of shares (2,500 units at $1.99), increasing direct ownership by 8% to 32,386 units (SEC Form 4)

    4 - CERUS CORP (0001020214) (Issuer)

    5/14/24 6:30:46 PM ET
    $CERS
    EDP Services
    Technology

    $ALBO
    $AMYT
    $AYI
    $BITF
    Leadership Updates

    Live Leadership Updates

    View All

    Bitfarms Announces Board Chair Transition in Anticipation of U.S. Redomiciliation

    TORONTO, Ontario and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX:BITF) ("Bitfarms" or the "Company"), a North American energy and digital infrastructure company, today announced that Edie Hofmeister has been appointed as Chair of the Board of Bitfarms. This appointment supports Bitfarms' previously announced strategy of redomiciling to the United States. Ms. Hofmeister succeeds Brian Howlett who has served as Director since 2020, and Chairman since 2024. Mr. Howlett will continue to serve as an Independent Director. Ms. Hofmeister brings over two decades of extensive expertise in legal affairs, corporate governance, and business strategy, developed over years in

    1/14/26 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Bitfarms Announces the Retirement of Jeff Lucas, Chief Financial Officer, and the Appointment of Jonathan Mir as Successor

    This news release constitutes a "designated news release" for the purposes of the Company's second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023. TORONTO and NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX:BITF) (the "Company"), a North American energy and digital infrastructure company, today announced the appointment of Jonathan Mir as Chief Financial Officer, effective October 27th, 2025. Bitfarms' current CFO, Jeff Lucas, will be retiring, and will remain on as a strategic financial advisor and consultant to the Company through Q1 2026 to ensure a smooth transition. Jonathan Mi

    10/14/25 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    Bitfarms Appoints Former AWS Executive Wayne Duso to Board of Directors

    TORONTO, Ontario and NEW YORK, N.Y., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (Nasdaq/TSX:BITF) (the "Company"), a global energy and compute infrastructure company, today announced that the Board of Directors (the "Board") has unanimously approved the appointment of Wayne Duso to the Company's Board, effective immediately. With the appointment of Mr. Duso, Bitfarms' Board is now comprised of seven directors, six of whom are independent. Mr. Duso is a distinguished senior engineering and product executive with over 25 years' experience developing enterprise technologies. He is renowned for his leadership in cloud storage systems that support large-scale data centers, making it eas

    8/18/25 7:00:00 AM ET
    $BITF
    Finance: Consumer Services
    Finance

    $ALBO
    $AMYT
    $AYI
    $BITF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cutera Inc.

    SC 13G/A - CUTERA INC (0001162461) (Subject)

    11/12/24 2:37:12 PM ET
    $CUTR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cerus Corporation

    SC 13G/A - CERUS CORP (0001020214) (Subject)

    11/12/24 9:53:11 AM ET
    $CERS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Acuity Brands Inc.

    SC 13G/A - ACUITY BRANDS INC (0001144215) (Subject)

    11/12/24 9:50:12 AM ET
    $AYI
    Building Products
    Consumer Discretionary

    $ALBO
    $AMYT
    $AYI
    $BITF
    Financials

    Live finance-specific insights

    View All

    Acuity Announces Increase in Quarterly Dividend

    Atlanta, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE:AYI) Board of Directors (the "Board") increases the quarterly dividend by 17% percent to 20 cents per share from 17 cents per share. The dividend is payable on February 13, 2026, to shareholders of record on February 2, 2026. About Acuity  Acuity Inc. (NYSE:AYI) is a market-leading industrial technology company. We use technology to solve problems in spaces, light and more things to come. Through our two business segments, Acuity Brands Lighting (ABL) and Acuity Intelligent Spaces (AIS), we design, manufacture, and bring to market products and services that make a valuable difference in people's lives. We achieve growth throug

    1/22/26 4:15:00 PM ET
    $AYI
    Building Products
    Consumer Discretionary

    Acuity Reports Fiscal 2026 First-Quarter Results

    Delivered Net Sales of $1.1B, an Increase of 20% Compared to the Prior YearDelivered Operating Profit of $160M, Up 20% Compared to the Prior Year; Grew Adjusted Operating Profit to $196M, Up 24% Compared to the Prior YearDelivered Diluted EPS of $3.82, Up 14% Compared to the Prior Year; Grew Adjusted Diluted EPS to $4.69, Up 18% Compared to the Prior Year ATLANTA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE:AYI), ("Acuity"), a market-leading industrial technology company, delivered net sales of $1.1 billion in the first quarter of fiscal 2026 ended November 30, 2025, an increase of $192.1 million, or 20.2 percent, compared to the prior year. "We delivered strong performance in ou

    1/8/26 6:00:00 AM ET
    $AYI
    Building Products
    Consumer Discretionary

    Acuity to Announce Fiscal 2026 First-Quarter Results on January 8, 2026

    ATLANTA, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE:AYI) (the "Company") will release fiscal 2026 first-quarter results on Thursday, January 8, 2026 at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. Neil Ashe, Chief Executive Officer of Acuity Inc., will lead the call. The webcast, earnings release, and supplemental presentation can be accessed via the Investor Relations section of the Company's website at www.investors.acuityinc.com on Thursday, January 8, 2026. The online replay will remain available for a limited time following the call. A replay of the call will also be posted to the Investor Relations site two hours after the completion of the conference call a

    12/1/25 4:15:00 PM ET
    $AYI
    Building Products
    Consumer Discretionary